A new Research Triangle company, Persistence Therapeutics, is developing a small, implantable device that generates and delivers genetically engineered T cells directly inside the body.
Pathogen persistence continues to challenge modern food processing, revealing hidden risks across the food supply. Explore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results